Activities of Several Antimicrobials against Mycobacterium ulcerans Infection in Mice

Author:

Dega Herve1,Robert Jerome1,Bonnafous Pascale1,Jarlier Vincent1,Grosset Jacques1

Affiliation:

1. Laboratoire de Bacteriologie, Facultéde Medecine Pitie-Salpetriere, Paris, France

Abstract

ABSTRACT Mycobacterium ulcerans inoculated into the footpads of mice at 6 × 10 3 CFU was shown to have a generation time of 6.5 days when estimated from weekly changes in microscopic counts of acid-fast bacilli (AFB) and 7.5 days when calculated from actual CFU enumerated on Lowenstein-Jensen egg medium incubated at 32°C. Footpads became swollen at week 10 (W10) after infection, and all infected control mice were dead at W15 after infection. Daily (5 days/week) treatment with 100 mg of clarithromycin (CLR)/kg of body weight beginning the day after infection prevented swelling of footpads at W10. When initiation of treatment was delayed until obvious footpad swelling was observed, there was a reduction in both the increase in AFB counts and deterioration of swollen footpads and also a prolonged survival of the mice to W18. Mice infected in the hind footpads with 5 × 10 5 CFU of M. ulcerans were divided into an untreated control group and six treatment groups that received one of the following therapies for 8 weeks: 100 mg of CLR/kg, 25 mg of minocycline (MIN)/kg, 50 mg of sparfloxacin (SPX)/kg, 10 mg of rifampin (RIF)/kg, 10 mg of rifabutin (RBT)/kg, or 100 mg of amikacin (AMK)/kg. After completion of therapy, treated animals were observed for an additional 17 weeks. All control mice and mice treated with CLR, MIN, or SPX exhibited swollen footpads during the observation period. In contrast, of those animals treated with RIF, RBT, or AMK, none had footpad swelling and all inoculated cultures done after the W17 observation remained negative. These results suggest that RIF, RBT, and AMK may be effective in the treatment of human infection with M. ulcerans .

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference19 articles.

1. Activity of clarithromycin against Mycobacterium avium complex in patients with the acquired immune deficiency syndrome.;Dautzenberg B.;Am. Rev. Respir. Dis.,1991

2. Mycobacterium ulcerans infections: response to chemotherapy in mice.;Feldman W. H.;Am. Rev. Tuberc.,1957

3. Pathogenic behavior of Mycobacterium ulcerans and Mycobacterium balnei in mouse and developing chick embryo.;Fenner F.;Am. Rev. Tuberc.,1956

4. Activity of rifampicin on Mycobacterium ulcerans.;Havel A.;Ann. Soc. Belge Med. Trop.,1975

5. Clarithromycin against Mycobacterium avium complex infections.;Heifets L. B.;Tuberc. Lung Dis.,1996

Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mycobacterium ulcerans Disease and Host Immune Responses;New Advances in Neglected Tropical Diseases;2023-02-22

2. Current Progress and Prospects for a Buruli Ulcer Vaccine;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

3. Vaccination efforts for Buruli ulcer;Expert Review of Vaccines;2022-08-24

4. Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer;Methods in Molecular Biology;2021-10-14

5. Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model;Antimicrobial Agents and Chemotherapy;2020-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3